coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rossendale West PCN, Rossendale · Health Inequalities Profile

    PCN U31504 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    44,075

    Registered population

    59.9% aged 18–64

    19.2%

    Aged 65+

    ICB 20.0% · England 17.9%

    9.4%

    Ethnic minority (non-White)

    7.3% Asian · England 9.6%

    26.4%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~10,562

    Core20 residents (est.)

    Resident basis; registered basis ~12,695 · see page 3

    7,090

    Hypertension register

    +9.16% in 3 yrs · England +5.60%

    498

    SMI register

    60.5% of Rossendale's

    965

    COPD register

    Reviews -1.56% in 3 yrs

    Forecast to 2030

    8,680

    Hypertension patients, 2030

    +1,590 on today

    68.2%

    QRISK ≥20% on statins, 2030

    +3.08pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.3%
    Under-80 blood pressure control trails England.

    Control in patients under 80 fell 4.2% (England +3.2%) to 61.3% (England 67.8%), whereas control in patients aged 80+ is 82.8% (England 81.2%).

    60.7%
    Annual asthma reviews fell over three years.

    Coverage fell 9.3% (England +4.4%) to 60.7% (England 65.7%) across 3,133 registered patients, leaving about 1,200 patients without a recorded review.

    83.6%
    Frail diabetes control and register growth.

    Frail diabetes HbA1c control reaches 83.6% (England 81.9%), non-frail diabetes control rose +11.9% (England +4.4%), and hypertension detection grew +9.2% (England +5.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older residents make up 19.2% of registered patients alongside 22 catchment care homes

    Across 44,075 registered patients across six practices, 19.2% (8,467) are aged 65+, compared to 17.6% in Rossendale, 20.0% in NHS Lancashire and South Cumbria Integrated Care Board, and 17.9% in England. Children aged 0-17 make up 20.9% (9,223 patients; Rossendale 21.0%, ICB 19.6%, England 19.6%). Based on Census usual residents rather than GP registrations, 7.3% identify as Asian / Asian British (Rossendale 5.5%, ICB 9.4%, England 9.6%), within a 9.4% non-White share. Population growth is projected at +1.6% to 2030 (Rossendale +1.2%, ICB +1.7%, England +2.3%), though projection methods are unverified.

    Age profile

    0–1720.9%
    18–6459.9%
    65+19.2%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White90.5%
    Asian7.3%
    Mixed1.5%
    Other0.4%
    Black0.2%

    Older people · falls rows are Rossendale local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rossendale LA)1,7992,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rossendale LA)8391,0219552024/25
    Falls deaths, all ages, per 100,000 (Rossendale LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 26.4% across the PCN and spans 57.7 pp between practices

    Across the PCN, 26.4% of registered patients live in Core20 areas, above England (21.0%) but below Rossendale (29.3%) and the ICB (30.6%). Deprivation is sharply uneven, spanning 57.7 pp from 6.4% at St James' Medical Centre to 64.1% at Fairmore Medical Practice. Concentration and volume diverge: Fairmore Medical Practice holds both the highest share and volume (3,921 estimated patients), but Haslingden Healthcare Ltd carries an estimated 2,940 patients at 27.3%. Practice estimates sum to 12,695 against a resident estimate of 10,562, requiring denominator reconciliation before targeting outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Fairmore Medical64.1% · 3,921 patients
    Hazelvalley42.7% · 2,674 patients
    Rossendale Valley41.9% · 1,093 patients
    Haslingden27.3% · 2,940 patients
    Ilex View Medical15.2% · 1,539 patients
    St James'6.4% · 528 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    498

    SMI register

    1.13% recorded prevalence

    287

    Learning disability register

    0.65% recorded prevalence

    22

    Care homes, 862 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Rossendale, Census 2021

    The PCN records 498 patients on its severe mental illness register (1.1%; Rossendale 1.1%, ICB 1.2%, England 1.0%) and 287 on its learning disability register (0.7%; Rossendale 0.7%, ICB 0.6%, England 0.6%), alongside 22 catchment care homes holding 862 beds.

    Severe mental illness: physical health checks

    Across published SMI physical-health checks, 80.9% had blood pressure recorded (England 83.4%) and 76.9% had BMI recorded (England 82.1%). Separate recording shows both components trail national levels, leaving scope to systematically close screening gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,090

    Hypertension register

    +9.16%

    Register growth, 3 yrs

    Rossendale +7.87% · England +5.60%

    −2.68pp

    BP control, under 80

    ≤140/90 · +1.95pp aged 80+

    +1,590

    More patients by 2030

    Forecast 8,680 (19.12%)

    Hypertension case-finding and control

    The hypertension register grew +9.2% over three years (England +5.6%) to 7,090 patients (16.0%, Rossendale 16.9%, England 15.2%), with 87.8% receiving a recent blood pressure check (England 90.0%). However, blood pressure control in patients aged under 80 fell 4.2% over three years (England +3.2%) to 61.3%, trailing Rossendale (64.2%) and England (67.8%), while overall treatment to target sits at 64.0% (England 70.3%). By contrast, control in patients aged 80 and over reached 82.8% (England 81.2%). This divergence could reflect titration delays, though local clinical audits are needed to test this. Fewer patients under 80 achieve blood pressure control than national benchmarks indicate, making focused titration reviews in under-80 cohorts the immediate priority.

    Lipids and statins

    For patients with QRISK ≥ 20%, 61.5% receive lipid-lowering therapy, below England (63.6%) and Rossendale (62.6%). Adult lipid-regulating prescribing reaches 2,523 items per 1,000 (England 4,100). Fewer at-risk patients receive lipid-lowering therapy than national rates imply, so systematic recall of eligible patients is the priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202687,942£1.60£1.64£1.86£140,707
    Cardiovascular (all), 2025127,331£3.43£3.38£3.33£436,745

    In 2026, the PCN prescribed 87,942 items of lipid-regulating drugs at £1.60 per item, below England (£1.86) but above Rossendale (£1.55). Across these items, the PCN spent £22,865 less than at England's unit cost. Lower unit costs than England do not reflect prescribing efficiency or case-mix, requiring local review of therapy choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −9.26%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.64%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.5% across 3,133 registered patients (England 6.6%). Annual asthma reviews fell 9.3% over three years (England +4.4%) to 60.7% (England 65.7%), leaving about 1,200 patients without a recorded review. Furthermore, second-hand smoke status recording in patients aged 6-19 with asthma reached 62.4% (England 78.8%). COPD prevalence sits at 2.2% across 965 patients, where annual reviews fell 1.6% (England +2.8%) to 73.3% (England 76.4%). Declining review rates point to an operational need to audit and restore routine respiratory monitoring.

    Cancer register and children's immunisation

    The cancer register grew +6.1% over three years (England +9.0%) to 1,727 patients (3.9% vs England 3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 reached 93.0% at 12 months. At age 5, MMR1 reached 93.0% whereas MMR2 was 82.0% (an 11 pp difference), and the 4-in-1 pre-school booster was 78.1%, below the 95.0% target by 16.9 pp. These cohort contrasts highlight a delivery gap in completing pre-school booster immunisations.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.0%

    England 91.0%

    6-in-1 complete primary course at 24 months88.8%

    England 92.2%

    MMR dose 1 at 24 months86.5%

    England 88.3%

    MMR dose 2 at age 582.0%

    England 82.8%

    4-in-1 pre-school booster at age 578.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage (4,642 of 8,863 staged cases out of 11,883 registered cancers; known stage 74.6%) were diagnosed at stage 1 or 2, below England (55.3%) and 22.6 pp below the 75.0% national ambition. From 2013 to 2022, this ICB share fell 1.2 pp. In Rossendale West PCN, cervical screening (25-49 years) is 69.2% but fell 3.7% over three years (England -1.0%), and breast screening is 73.3% but fell 0.6% (England +8.4%). Cancer register growth reached +6.1% (England +9.0%). Screening declines may affect early detection, though ICB staging reflects wider system pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Lancashire Hospitals NHS Trust achieved 73.2% against the 85.0% 62-day referral to treatment standard (Northern Care Alliance NHS Foundation Trust 78.6%, Bolton NHS Foundation Trust 69.7%, NHS Lancashire and South Cumbria Integrated Care Board 73.6%, England 71.2%). For the 28-day faster diagnosis standard, East Lancashire reached 81.5% (Bolton NHS Foundation Trust 80.5%, Northern Care Alliance NHS Foundation Trust 75.2%, ICB 78.4%, England 79.3%), above the 75.0% standard. In diagnostics, 32.7% of cystoscopy patients waited 6+ weeks at East Lancashire (England 24.4%), while MRI 6+ week waits were 0.4% (England 21.4%).

    Pathways within standard (%)East LancashireNorthern Care AllianceBoltonLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5075.2080.4878.3979.32
    31-day treatment (96%)98.1194.5496.5093.6292.50
    62-day referral to treatment (85%)73.1678.6569.6673.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireNorthern Care AllianceBoltonEngland
    MRI0.435.092.0521.40
    CT0.154.1019.409.92
    Echocardiography0.0031.483.4828.48
    Colonoscopy0.9540.041.3330.83
    Gastroscopy1.1636.482.0629.02
    All 15 DM01 tests3.2515.7115.7823.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026 (provisional), community service contacts for Rossendale borough residents totalled 126,445, with 72,000 contacts involving adults aged 65+, representing 56.9% of all contacts. These figures reflect wider local authority resident activity rather than a PCN cohort, showing substantial community service reliance among older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 64.5 pp and phone access varies by 33.5 pp

    In 2025/26, QOF overall achievement was 88.4% at Fairmore Medical Practice and 97.6% at Haslingden Healthcare Ltd (England 92.5%). Vaccination and immunisation achievement spans 64.5 pp, with Fairmore Medical Practice achieving 15.6% and Haslingden Healthcare Ltd reaching 80.1% (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hazelvalley9042.779.2%79.1%90.7%
    Haslingden11027.380.5%78.0%88.4%
    Ilex View Medical10515.265.1%75.0%82.3%
    St James'1186.453.1%79.7%81.9%
    Rossendale Valley9741.986.7%68.1%80.4%
    Fairmore Medical11464.154.1%65.3%74.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRossendaleAssetPCNRossendale
    Care homes (catchment)22 (862 beds)n/aSchools (catchment)61n/a
    Children's centres35Places of worship5044
    Libraries34Homelessness support (VCS)n/a1
    Primary schools (LA maintained)2225Primary academies22
    Special schools21

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and smoke recall

    Annual asthma reviews fell 9.3% (England +4.4%) to 60.7% (England 65.7%) across 3,133 patients, leaving 1,232 (about 1,200) unreviewed; youth second-hand smoke recording is 62.4% (England 78.8%). For discussion: practices could run a single-template asthma recall offering after-school slots and combined inhaler and second-hand smoke checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Under-80 hypertension titration and case-finding

    Under-80 BP control fell 4.2% (England +3.2%) to 61.3% (England 67.8%) and treatment to target is 64.0% (England 70.3%); the 7,090 register (16.0%) sits 367 below Rossendale (16.9%) and 377 above England (15.2%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    COPD annual review and register validation

    COPD reviews fell 1.6% (England +2.8%) to 73.3% (Rossendale 78.0%, England 76.4%); the crude register of 965 patients (2.2%) sits 178 below Rossendale (2.6%) and 130 above England (1.9%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted cultural access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Blood pressure titration audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster call-recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening call-recall and uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review and smoke recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Under-80 hypertension titration and case-finding (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · COPD annual review and register validation (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15